Flunisolide Nasal Inhalation |
Nasarel; Nasolide (Removed from Market) |
Clinical Trial: Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
This study is not yet open for patient recruitment.
|
Purpose
The purpose of this study is to determine whether asthmatics have different adenosine receptor expression profiles than healthy controls. We hypothesize that asthmatics will have increased adenosine receptor expression versus control subjects.
We also want to study the effects of allergen inhalation on adenosine receptor expression in asthmatics. We believe that adenosine receptor expression will be upregulated after allergen inhalation.
Both hypotheses are being tested in sputum and peripheral blood.
| Condition | Intervention |
|---|---|
| Asthma Healthy | Behavior: allergen inhalation Behavior: withdrawal of medication Procedure: sputum induction |
MedlinePlus related topics: Asthma
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title: Effects of Allergen Inhalation on Adenosine Receptor Expression and Mast Cell Activation in Peripheral Blood and Sputum of Asthmatics and Healthy Subjects
Expected Total Enrollment: 20
Study start: July 2005
Last follow-up: July 2006
Eligibility
Accepts Healthy Volunteers
Asthmatic Subjects - Inclusion Criteria:
- Clinical diagnosis of asthma
- Steroid naive or subjects not using their inhaled steroids for the last 4 weeks, short-acting beta-agonist for rescue medication
- FEV1 > 70% of predicted
- Positive skin prick test for house dust mite, cat or grass pollen
- PC20 methacholine or histamine < 8 mg/ml
Asthmatic Subjects - Exclusion Criteria:
- Use of systemic steroids in the previous 6 weeks
- Asthma exacerbations in the previous 6 weeks
- Current or ex-smokers with ≥ 10 pack-years (≥ 2 pipe pack-years), ex smokers who stopped less than 1 year ago
Healthy Subjects - Inclusion Criteria:
- No airway complaints
- FEV1 > 90% of predicted
- Negative skin prick test
- PC20 methacholine or histamine > 8 mg/ml
Healthy Subjects - Exclusion Criteria:
- Use of steroids in the previous 6 weeks
- Current or ex-smokers with ≥ 10 pack-years (≥ 2 pipe pack-years), ex smokers who stopped less than 1 year ago
Location and Contact Information
Netherlands
University Medical Center Groningen, Department of Pulmonology, Groningen, 9713 GZ, Netherlands
Mieke Versluis, PhD-student, Sub-Investigator
Dirkje S Postma, prof. MD PhD, Principal Investigator, University Medical Center Groningen, Department of Pulmonology, hanzeplein 1, 9713 GZ Groningen, The Netherlands
More Information
Record last reviewed: June 2005
Last Updated: June 30, 2005
Record first received: June 28, 2005
ClinicalTrials.gov Identifier: NCT00116311
Health Authority: Netherlands: Dutch Health Care Inspectorate
ClinicalTrials.gov processed this record on 2005-07-05

Not Signed In -


